NKTR

Nektar Therapeutics News Headlines

$14.26
*  
0.05
0.35%
Get NKTR Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading NKTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Nektar 181 Could Dominate A $13B Chronic Pain Market
8/26/2014 8:33:00 AM - Seeking Alpha

Monday's ETF Movers: FBT, GDX
8/25/2014 1:07:02 PM - BNK Invest

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog
8/22/2014 6:30:00 PM - Zacks.com

Nektar Therapeutics Has More To Give
8/21/2014 1:45:00 PM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha

Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik
8/7/2014 12:36:00 PM - Seeking Alpha

Nektar President Howard Robin Is Listening To You
8/4/2014 8:59:00 AM - Seeking Alpha

Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog
8/1/2014 1:53:00 PM - Zacks.com

Nektar Therapeutics Q2 Loss Narrows
7/31/2014 6:17:00 PM - RTT News

Nektar Therapeutics Q2 14 Earnings Conference Call At 5:00 PM ET
7/31/2014 3:02:00 PM - RTT News

Sell-Off On Wall Street Drags Dow To Two-Month Low - U.S. Commentary
7/31/2014 12:15:00 PM - RTT News

Nektar: Reason Will Rarely Fail You
7/28/2014 10:24:00 AM - Seeking Alpha

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/18/2014 8:00:00 AM - Zacks.com

AstraZeneca's Naloxegol Data Published - Analyst Blog
6/20/2014 6:00:00 PM - Zacks.com

Regado Biosciences: The Revolyxis Revolution Has Begun
6/17/2014 12:20:00 PM - Seeking Alpha

Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77% - Tale of the Tape
6/16/2014 8:44:00 AM - Zacks.com

A Nektar Victory
6/14/2014 1:50:00 PM - Seeking Alpha

Relief for Nektar after AADPAC Voting - Analyst Blog
6/13/2014 6:10:00 PM - Zacks.com

Nektar Therapeutics (NKTR) Is Up Sharply After FDA Panel Vote
6/13/2014 9:50:00 AM - RTT News

Stocks Extending Upward Move, Dow And S&P 500 Set New Highs - U.S. Commentary
6/9/2014 12:04:00 PM - RTT News

Friday's ETF Movers: ILF, FBT
6/6/2014 1:20:56 PM - BNK Invest

Bullish Two Hundred Day Moving Average Cross - NKTR
5/29/2014 4:30:26 PM - BNK Invest

Celldex: The Race Leader In Glioblastoma Multiforme
5/29/2014 3:17:00 PM - Seeking Alpha

Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha

NKTR September 20th Options Begin Trading
5/21/2014 11:05:02 AM - BNK Invest